Sanjay Gurunathan

Infectious Disease

1 Discovery Dr
Swiftwater, PA 18370

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Live-Attenuated Intranasal RSV Vaccine in Infants and Toddlers.

Live-Attenuated Intranasal RSV Vaccine in Infants and Toddlers.

Journal: NEJM evidence

Published: August 26, 2025

Safety and immunogenicity of investigational herpes simplex virus-2 vaccines in adults with recurrent genital infection.

Safety and immunogenicity of investigational herpes simplex virus-2 vaccines in adults with recurrent genital infection.

Journal: Vaccine

Published: August 15, 2025

First Among Equals: The Case for High-quality Clinical Data in Influenza Vaccines.

First Among Equals: The Case for High-quality Clinical Data in Influenza Vaccines.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: March 12, 2025

Vaccine Induced Seroreactivity Following Administration of ALVAC-HIV/AIDSVAX®B/E Identified by Common Anti-HIV Test Kits and Algorithms in Thailand.

Vaccine Induced Seroreactivity Following Administration of ALVAC-HIV/AIDSVAX®B/E Identified by Common Anti-HIV Test Kits and Algorithms in Thailand.

Journal: Open forum infectious diseases

Published: February 21, 2025

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial.

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial.

Journal: PLOS global public health

Published: May 10, 2024

Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccine.

Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccine.

Journal: medRxiv : the preprint server for health sciences

Published: February 14, 2024

Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccine.

Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccine.

Journal: JCI insight

Published: January 03, 2024

Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production.

Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production.

Journal: Frontiers in immunology

Published: November 16, 2023

"Direct and indirect impacts of the COVID-19 pandemic on operational conduct of pediatric vaccine clinical trials".

"Direct and indirect impacts of the COVID-19 pandemic on operational conduct of pediatric vaccine clinical trials".

Journal: Human vaccines & immunotherapeutics

Published: November 09, 2023

Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector function magnitude but not durability.

Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector function magnitude but not durability.

Journal: AIDS (London, England)

Published: June 01, 2023

Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120.

Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120.

Journal: The Journal of infectious diseases

Published: May 27, 2023

Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study.

Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study.

Journal: EClinicalMedicine

Published: May 24, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026